Blind Docking Server

Blind Docking Server performs blind docking to identify potential ligand interaction sites across protein surfaces from ligand and protein structures, supporting drug discovery and molecular biology studies.

Key Features:

• Blind docking across full protein surface: Performs docking across the entire protein surface to detect possible binding sites without prior site specification.
• Identification of non-obvious interaction sites: Detects potential ligand–protein interactions that may be missed by traditional docking constrained to predefined sites.
• Applicable to small molecules and protein variants: Can analyze interactions involving small molecules such as MCC950 and protein targets including wild-type and mutant NLRP3.
• Analysis of ligand-induced conformational effects: Enables characterization of ligand-induced conformational changes such as closing the "open" conformation of active NLRP3.

Scientific Applications:

• Drug discovery and mechanism studies: Identification of novel binding sites and characterization of ligand–protein interactions to inform therapeutic development.
• Investigating MCC950 mechanism of action: Characterizing how MCC950 interacts with NLRP3 to elucidate its inhibitory mechanism.
• Comparative analysis of wild-type and mutant NLRP3: Comparing interactions to understand effects of mutations and ligand-induced conformational changes.
• Disease-relevant research: Analysis of MCC950–NLRP3 interactions relevant to monogenic autoinflammatory syndromes, gout, atherosclerosis, and Alzheimer's disease.

Methodology:

Processes ligand and target protein structures and performs blind docking calculations by scanning the entire protein surface to identify potential interaction sites.